Jesús Sánchez-Ballesteros

Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial

Jesús Villar, Carlos Ferrando, Domingo Martínez et al. · The Lancet Respiratory Medicine · 2020 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +7

Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study

John G. Laffey, Fabiana Madotto, Giacomo Bellani et al. · The Lancet Respiratory Medicine · 2017 · 126 citations · Full text

Medicine, Health Sciences, Cost-effectiveness Analysis +11

Predicting ICU Mortality in Acute Respiratory Distress Syndrome Patients Using Machine Learning: The Predicting Outcome and STratifiCation of severity in ARDS (POSTCARDS) Study*

Jesús Villar, Jesús M. González‐Martín, Jerónimo Hernández-González et al. · Critical Care Medicine · 2023 · 62 citations · Full text

Medicine, Health Informatics, Clinical Decision Support +16

Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial

Jesús Villar, José M. Añón, Carlos Ferrando et al. · Trials · 2020 · 56 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +17

Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies

Luigi Pisani, Anna Geke Algera, Ary Serpa Neto et al. · The Lancet Global Health · 2021 · 45 citations · Full text

Medicine, Respiratory Therapy, Pulmonology +10